Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics
Open Access
- 1 September 1993
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 110 (1) , 482-490
- https://doi.org/10.1111/j.1476-5381.1993.tb13836.x
Abstract
1 To explain the large differences in (the stereoselectivity of) the clearances of the enantiomers of warfarin and acenocoumarol (4′-nitrowarfarin) their human liver microsomal metabolism has been studied and enzyme kinetic parameters determined. The effects of cimetidine, propafenone, sulphaphenazole, and omeprazole on their metabolism has been investigated. 2 The 4-hydroxycoumarins follow similar metabolic routes and are mainly hydroxylated at the 6- and 7-position (accounting for 63 to 99% of the metabolic clearances). 3 Due to the lower Km values of R- and S-acenocoumarol and higher Vmax values of S-acenocoumarol, the overall metabolic clearances of R/S acenocoumarol exceed those of R/S warfarin 6 and 66 times respectively. 4 The metabolism of both compounds is stereoselective for the S-enantiomers, which is 10 times more pronounced in the case of acenocoumarol. 5 Except for the 7-hydroxylation of the R-enantiomers (r = 0.90; P < 0.025), the 6- and 7-hydroxylation rates of R/S warfarin do not correlate with those of R/S acenocoumarol. 6 Sulphaphenazole competitively inhibits the 7- and in some samples partly (up to 50%) the 6-hydroxylation of S-warfarin as well as the 7-hydroxylation of R- and S-acenocoumarol and the 6-hydroxylation of S-acenocoumarol (Kis ranging from 0.5– 1.3 μm). 7 Omeprazole partly (40–80%) inhibits the 6- and 7-hydroxylation of R-warfarin (Ki = 99 and 117 μm) and of R- (Ki = 219 and 7.2 μm) and S-acenocoumarol (Ki = 6.1 and 7.7 μm) but not S-warfarin in a competitive manner. 8 Differences in the partial (up to 40%) inhibition of the metabolism of the enantiomers of the 4-hydroxycoumarins were also observed for the relatively weak inhibitors, propafenone and cimetidine. 9 The results suggest that the coumarin ring hydroxylations of both compounds are catalysed by different combinations of P450 isozymes. The 7-hydroxylation of R/S acenocoumarol and the 6-hydroxylation of S-acenocoumarol are at least partly conducted by (a) P450 isozyme(s) of the 2C subfamily different from P450 2C9 (the main S-warfarin 7- and 6-hydroxylase).Keywords
This publication has 42 references indexed in Scilit:
- Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactionsChemical Research in Toxicology, 1992
- Omeprazole Drug Interaction StudiesClinical Pharmacokinetics, 1991
- Comparison of the rat liver microsomal metabolism of the enantiomers of warfarin and 4′-nitrowarfarin (Acenocoumarol)Xenobiotica, 1991
- Enantioselective Structure-pharmacokinetic Relationships of Ring Substituted Warfarin Analogues in the RatJournal of Pharmacy and Pharmacology, 1990
- Stereoselective Interaction of Omeprazole with Warfarin in Healthy MenTherapeutic Drug Monitoring, 1989
- Warfarin as A Probe of Cytochromes P 450 FunctionDrug Metabolism Reviews, 1989
- Clinical Pharmacokinetics and Pharmacodynamics of WarfarinClinical Pharmacokinetics, 1986
- Stereoselective Interaction of Trimethoprim-Sulfamethoxazole with the Separated Enantiomorphs of Racemic Warfarin in ManNew England Journal of Medicine, 1980
- Clinical Pharmacokinetics of Oral AnticoagulantsClinical Pharmacokinetics, 1979
- Post mortem characteristics of the hepatic microsomal drug oxidising enzyme systemChemico-Biological Interactions, 1973